Drugs / AFP peptide-pulsed autologous DC
last change Oct 2008 re-read 3 minutes ago

AFP peptide-pulsed autologous DC

also known as AFP
Developed for
liver cancer
Investigated by
Jonsson Comprehensive Cancer Center · National Institutes of Health (NIH)

Trials 1

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00022334 Jan 2001 → Dec 2004 liver cancer Jonsson Comprehensive Cancer Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AFP peptide-pulsed autologous DC “AFP peptide-pulsed autologous DC” NCT00022334 ↗
Known as AFP ClinicalTrials.gov intervention name — accepted as the source's own label NCT00022334 ↗